Abstract
China approves five genetically modified crops. China’s science awards further encourage innovation. Severe and prolonged air pollution affects productivity of workers. Negative population growth looms ahead for China. Genetically-enhanced human blood vessel cells. New bat-borne virus related to Ebola. China’s homegrown anti-cancer drug wins international recognition. Tariff changes aim to cut drug prices. New procurement scheme to reduce drug prices. China brings more new drugs to market with fast-track approval. Tougher supervision vowed over food and drugs. Project seeks uniformity in treatment of China’s number one killer. Great potential seen in AI-powered medical imaging. Updates from China’s life sciences industry.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
